Business Description
Nextbiomedical Co Ltd
ISIN : KR7389650003
Compare
Compare
Traded in other countries / regions
389650.Korea IPO Date
2024-08-20Description
Nextbiomedical Co Ltd is an bio-solution company. The company develops and commercializes therapeutic agents for treating diseases based on polymer and drug delivery system technology. The company has developed products that include endoscopic hemostatic agents, vascular embolic microspheres, and others.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.24 | |||||
| Equity-to-Asset | -0.2 | |||||
| Debt-to-Equity | -1.95 | |||||
| Debt-to-EBITDA | -1.78 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.48 | |||||
| Beneish M-Score | -2.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.8 | |||||
| 3-Year EBITDA Growth Rate | 41.8 | |||||
| 3-Year EPS without NRI Growth Rate | 7.5 | |||||
| 3-Year FCF Growth Rate | 10.7 | |||||
| 3-Year Book Growth Rate | 53.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 77.45 | |||||
| 9-Day RSI | 69.1 | |||||
| 14-Day RSI | 64.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.53 | |||||
| Quick Ratio | 0.47 | |||||
| Cash Ratio | 0.42 | |||||
| Days Inventory | 270.38 | |||||
| Days Sales Outstanding | 46.09 | |||||
| Days Payable | 6.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.6 | |||||
| Shareholder Yield % | -0.13 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.19 | |||||
| Operating Margin % | -107.05 | |||||
| Net Margin % | -154.06 | |||||
| FCF Margin % | -86.53 | |||||
| ROA % | -24.35 | |||||
| ROIC % | -11.63 | |||||
| ROC (Joel Greenblatt) % | -59.98 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 58.19 | |||||
| EV-to-EBIT | -53.97 | |||||
| EV-to-EBITDA | -57.86 | |||||
| EV-to-Revenue | 76.8 | |||||
| EV-to-FCF | -83.01 | |||||
| Earnings Yield (Greenblatt) % | -1.85 | |||||
| FCF Yield % | -1.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nextbiomedical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 4,882.233 | ||
| EPS (TTM) (â‚©) | -1198 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 64.81 | ||
| 14-Day ATR (â‚©) | 3646.815575 | ||
| 20-Day SMA (â‚©) | 41377.5 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (â‚©) | 21400 - 52100 | ||
| Shares Outstanding (Mil) | 8.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nextbiomedical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nextbiomedical Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nextbiomedical Co Ltd Frequently Asked Questions
What is Nextbiomedical Co Ltd(XKRX:389650)'s stock price today?
The current price of XKRX:389650 is â‚©48250.00. The 52 week high of XKRX:389650 is â‚©52100.00 and 52 week low is â‚©21400.00.
When is next earnings date of Nextbiomedical Co Ltd(XKRX:389650)?
The next earnings date of Nextbiomedical Co Ltd(XKRX:389650) is .
Does Nextbiomedical Co Ltd(XKRX:389650) pay dividends? If so, how much?
Nextbiomedical Co Ltd(XKRX:389650) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers